Fulgent Genetics, Inc.
(NASDAQ: FLGT)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

26.110 -

-0.290 (-1.10%)
Range 25.850 - 26.455   (2.34%)
Open 26.430
Previous Close 26.400
Bid Price 26.090
Bid Volume 2
Ask Price 26.130
Ask Volume 22
Volume 33,573
Value 622,717
Remark -
Delayed prices. Updated at 30 Jan 2026 01:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis